Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 6:2023:9212524.
doi: 10.1155/2023/9212524. eCollection 2023.

Postintravitreal Injection Endophthalmitis: Incidence, Characteristics, Management, and Outcome

Bar Davidov  1   2 , Avi Ohayon  1   2   3   4 , Omer Trivizki  1   2   3   4 , Shulamit Schwartz  1   2 , Shiri Shulman  3   4
Affiliations

Postintravitreal Injection Endophthalmitis: Incidence, Characteristics, Management, and Outcome

Bar Davidov et al. J Ophthalmol. .

Abstract

Purpose: Postintravitreal injection (IVI) endophthalmitis is a rare but devastating complication. Herein, we report the incidence ,and clinical and microbiological characteristics, as well as the visual outcome, in IVIs endophthalmitis in two medical centers.

Methods: All patients undergoing intravitreal injections between 1/2018 and 12/2019 in two large medical centers were analyzed for post-IVI endophthalmitis.

Results: Of the total of 51,356 IVIs performed, 23 cases of post-IVI endophthalmitis were diagnosed, yielding an overall incidence of 0.045%. The median interval from IVI to symptoms onset was 2 days (IQR: 1-5). Cultures were positive in 56% of the cases (100% Gram-positive bacteria and 76% coagulase-negative staphylococcus). Parameters associated with higher culture-positive rates included samples taken during vitrectomy, WBC on vitreous smear, the number of IVIs in the 12 months prior to presentation, and the time interval from last IVI to diagnostic sampling. At 6- and 12-month follow-up, the median change in VA (logMAR) was -1.10 (IQR: (-1.32)-(-0.40)) and -1.02 (IQR: (-1.10)-(-0.30)), respectively. Younger age and better BCVA at presentation were associated with better VA outcome, while positive culture result and systemic steroids treatment were each associated with the worse visual outcome. We found no difference in visual outcomes between PPV and TAI as a primary procedure.

Conclusion: Post-IVI endophthalmitis is a rare complication, and most patients do not regain their initial VA. Certain parameters (clinical, microbiological, and therapeutic) may help anticipate the outcome and guide decision making regarding diagnosis and treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest.

Figures

Figure 1
Figure 1
BCVA distribution along the study period.
See this image and copyright information in PMC

References

    1. Fileta J. B., Scott I. U., Flynn H. W., Flynn H. W. Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmic Surg Lasers Imaging Retina . 2014;45(2):143–149. doi: 10.3928/23258160-20140306-08. - DOI - PubMed
    1. Moshfeghi A. A., Lee W. H., Flynn H. W., et al. Endophthalmitis after intravitreal anti-vascular endothelial growth factor antagonists: a six-year experience at a university referral center. Retina . 2011;31(4):662–668. doi: 10.1097/iae.0b013e31821067c4. - DOI - PubMed
    1. Storey P., Dollin M., Pitcher J., et al. The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection. Ophthalmology . 2014;121(1):283–289. doi: 10.1016/j.ophtha.2013.08.037. - DOI - PubMed
    1. Relhan N., Forster R. K., Flynn H. W., Flynn H. W. Endophthalmitis: then and now. American Journal of Ophthalmology . 2018;187 doi: 10.1016/j.ajo.2017.11.021. - DOI - PMC - PubMed
    1. Dave V. P., Pathengay A., Relhan N., et al. Endophthalmitis and Concurrent or Delayed-Onset Rhegmatogenous Retinal Detachment Managed With Pars Plana Vitrectomy. Intravitreal Antibiotics, and Silicone Oil . 2017;48 doi: 10.3928/23258160-20170630-05. - DOI - PubMed

LinkOut - more resources